Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Seer, Inc. Banner

Seer, Inc.

SEER Stock Analysis

Page title

Section title

About Seer, Inc.

Biotechnology
Healthcare

Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It has a collaboration agreement with Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences, Inc...

Seer, Inc. Key Metrics

Market Cap
$109M
52 Weeks Low
$1.46
52 Weeks High
$2.48
P/B
0.31x
P/E
-1.39x
P/S
7.69x

Upcoming Events

    SEER Analyst Forecasts



    SEER Financials

    SEER Income Statement Key Metrics

    • Revenue(TTM)14.13 M
    • Gross Profit(TTM)2.07 M
    • EBITDA(TTM)-94.60 M
    • Net Income(TTM)-82.42 M
    • EPS Diluted(TTM)-1.28

    Decode SEER's Latest Earnings Call with Ease

    Tap 'Generate' for a crystal-clear,
    AI-crafted summary and stay ahead in the investment game!

    SEER earnings and revenue history

    Gross Profit Margin vs Peers

    Profit margin ratio of SEER (0.095) is higher than the average of its peers (-8.953).

    Net Profit Margin vs Peers

    Net profit margin ratio of SEER (-5.683) is higher than the average of its peers (-111.003).

    SEER Return on Equity

    See how efficiently SEER generates profit for it's shareholders.

    -21.74%

    10
    0
    100
    1. Poor

    2. Average

    3. Strong

    Return on Equity vs Peers

    Return on Equity ratio of SEER (-0.217) is higher than the average of its peers (-0.390).

    Return on Equity Growth

    SEER's Return on Equity has shown poor growth over the past 10 years, increasing by only 0.54%.

    SEER Revenue Growth

    See how SEER has grown it's revenue over the past 10 years.


    Revenue Growth

    SEER's revenue has grown significantly over the past 10 years, increasing by over 0%.